BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25967349)

  • 21. Endogenous phospholipase D2 localizes to the plasma membrane of RBL-2H3 mast cells and can be distinguished from ADP ribosylation factor-stimulated phospholipase D1 activity by its specific sensitivity to oleic acid.
    Sarri E; Pardo R; Fensome-Green A; Cockcroft S
    Biochem J; 2003 Jan; 369(Pt 2):319-29. PubMed ID: 12374567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcellular distribution and characterization of rat pancreatic phospholipase D isoforms.
    Lainé J; Bourgoin S; Bourassa J; Morisset J
    Pancreas; 2000 May; 20(4):323-36. PubMed ID: 10824686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Insights for Drugs Developed for Phospholipase D Enzymes.
    Stieglitz KA
    Curr Drug Discov Technol; 2018; 15(2):81-93. PubMed ID: 28814238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phospholipase D is activated and phosphorylated by casein kinase-II in human U87 astroglioma cells.
    Ahn BH; Min G; Bae YS; Bae YS; Min DS
    Exp Mol Med; 2006 Feb; 38(1):55-62. PubMed ID: 16520553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The phospholipase D pathway mediates the inflammatory response of the retinal pigment epithelium.
    Mateos MV; Kamerbeek CB; Giusto NM; Salvador GA
    Int J Biochem Cell Biol; 2014 Oct; 55():119-28. PubMed ID: 25172550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of choline for acetylcholine synthesis by phospholipase D isoforms.
    Zhao D; Frohman MA; Blusztajn JK
    BMC Neurosci; 2001; 2():16. PubMed ID: 11734063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel ketoepoxides block phospholipase D activation and tumor cell invasion.
    Pai JK; Frank EA; Blood C; Chu M
    Anticancer Drug Des; 1994 Aug; 9(4):363-72. PubMed ID: 7916902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in EL4 lymphoma cells.
    Knoepp SM; Chahal MS; Xie Y; Zhang Z; Brauner DJ; Hallman MA; Robinson SA; Han S; Imai M; Tomlinson S; Meier KE
    Mol Pharmacol; 2008 Sep; 74(3):574-84. PubMed ID: 18523140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NFkappaB-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells.
    Kang DW; Park MH; Lee YJ; Kim HS; Kwon TK; Park WS; Min do S
    J Biol Chem; 2008 Feb; 283(7):4094-104. PubMed ID: 18084005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphatidylinositol (3,4,5)-trisphosphate specifically interacts with the phox homology domain of phospholipase D1 and stimulates its activity.
    Lee JS; Kim JH; Jang IH; Kim HS; Han JM; Kazlauskas A; Yagisawa H; Suh PG; Ryu SH
    J Cell Sci; 2005 Oct; 118(Pt 19):4405-13. PubMed ID: 16179605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of protein kinase C pathway in UVC-stimulated phospholipase D2 activity in Vero 76 cells.
    Kim S; Choi MS; Choi MU
    Exp Mol Med; 2005 Oct; 37(5):418-26. PubMed ID: 16264266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ral isoforms are implicated in Fc gamma R-mediated phagocytosis: activation of phospholipase D by RalA.
    Corrotte M; Nyguyen AP; Harlay ML; Vitale N; Bader MF; Grant NJ
    J Immunol; 2010 Sep; 185(5):2942-50. PubMed ID: 20679536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PLD regulates myoblast differentiation through the mTOR-IGF2 pathway.
    Yoon MS; Chen J
    J Cell Sci; 2008 Feb; 121(Pt 3):282-9. PubMed ID: 18198186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phospholipases D1 and D2 Suppress Appetite and Protect against Overweight.
    Trujillo Viera J; El-Merahbi R; Nieswandt B; Stegner D; Sumara G
    PLoS One; 2016; 11(6):e0157607. PubMed ID: 27299737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting Phospholipase D Genetically and Pharmacologically for Studying Leukocyte Function.
    Gomez-Cambronero J; Ganesan R
    Methods Mol Biol; 2018; 1835():297-314. PubMed ID: 30109659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitor.
    Lavieri RR; Scott SA; Selvy PE; Kim K; Jadhav S; Morrison RD; Daniels JS; Brown HA; Lindsley CW
    J Med Chem; 2010 Sep; 53(18):6706-19. PubMed ID: 20735042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of phospholipase D isoforms in mammalian cells.
    Meier KE; Gibbs TC; Knoepp SM; Ella KM
    Biochim Biophys Acta; 1999 Jul; 1439(2):199-213. PubMed ID: 10425396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins.
    Jenco JM; Rawlingson A; Daniels B; Morris AJ
    Biochemistry; 1998 Apr; 37(14):4901-9. PubMed ID: 9538008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phospholipase D1 as a key enzyme for decidualization in human endometrial stromal cells.
    Yoon MS; Koo JB; Jeong YG; Kim YS; Lee JH; Yun HJ; Lee KS; Han JS
    Biol Reprod; 2007 Feb; 76(2):250-8. PubMed ID: 17065600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed apoptosis and modulation of phospholipase D activity by plasmid containing mammalian cDNA in human neutrophils.
    Lee SY; Kim JW; Jin JO; Song MG; Park JI; Min do S; Kwak JY
    Biochem Biophys Res Commun; 2006 Sep; 347(4):1039-47. PubMed ID: 16870152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.